When

Thursday, July 25, 2024

12:00 PM-1:00 PM CT

WheRE

Bessemer, AL

Aletheia House
Conference Room
2201 Arlington Ave.
Bessemer, AL 35020

faculty
Gregory Felzien, MD, AAHIVS
Diplomat: Internal Medicine and Infectious Disease
Medical Director
Positive Impact Health Centers
Atlanta, Georgia

Target Audience

This educational initiative is intended for addiction center clinical staff (MDs, NPs, PAs, RNs), counselors, social workers, case managers, peer educators, peer advocates, medical assistants, and non-clinical office staff.

Learning Objectives

Upon completion of this program, participants will be better able to:

  • Summarize HIV epidemiology and at-risk behaviors among PWID

  • Evaluate HIV risk and PrEP eligibility of individuals participating in SUD services

  • Counsel PWID regarding HIV prevention, including PrEP options and comprehensive harm reduction

Program Description

This empowering grassroots initiative is designed to educate and encourage clinicians and other providers working in substance use disorder (SUD) centers in metropolitan and less-populated areas to increase their clients’ awareness of and access to preexposure prophylaxis (PrEP) for HIV prevention. Small live meetings for community-based groups will offer medical and addiction-services specialists innovative methods to collaboratively engage people who inject drugs (PWID) and link them to providers for HIV testing and PrEP services. At these educational events, participants will interact directly with HIV prevention experts who will convey clinical data integrated with real-world experience and insights and provide takeaway print media and online resources for participants to use and share in the practice setting. The program will provide practical resources to connect PWID with local PrEP providers so that they can benefit from the care they need and deserve.

Agenda

  • The Critical Role for Substance Use Disorder (SUD)-Treatment Providers at the Intersection of Opioid Use Disorder and HIV Risk
  • HIV Testing 101: Guidelines, Tactics, and Tips
  • Introduction to HIV Preexposure Prophylaxis (PrEP)
  • Effective SUD-Center–Based PrEP Screening-and-Referral Models
  • Audience Q&A

Physician Accreditation Statement

Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Integritas designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Accreditation Statement

Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 1.0 contact hour, including 0.0 pharmacotherapeutic contact hour, is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relevant Financial Relationships

Integritas Communications and Global Education Group adhere to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

Gregory “Grey” Felzien, MD, AAHIVS

Consultant: ViiV Healthcare

The planners and managers at Integritas Communications and Global Education Group have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Mara Simpson prior to the live event at msimpson@integritasgrp.com.

Contact Information

For information about the accreditation (ACCME credit) of this program, please contact Integritas at info@exchangecme.com.

For information about the accreditation (ANCC) of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

 

Register Now

attend event
available resources
linked resources
Patient Educational Resources

BRIDGE PrEP

Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention